Search

everythinglearnresearchcommunity

for

Search:↓

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Piedraia hortae fungi dissolve both the outer and inner layers of hair.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Hair loss in men is common, treatable, but not curable.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Probiotic bacteria improved skin and hair health in aged mice.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Key genes and factors crucial for hair follicle development and wool traits in Merino sheep were identified.

Hair loss in men treated best with early medication or transplant, new treatments researched.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.